Skip to content
Monday, November 16, 2026
Global Reels Hub

Individuals Coming Off Anti-Obesity Injections Regain Weight at a Quadrupled Rate Than Those on Conventional Diets

Illustration of medical injection and scale
Weight management involves ongoing approaches.

A recent study suggests that individuals who discontinue new GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle plans.

Research printed in a major health publication shows that while obese people can lose about a fifth of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.

"People purchasing these medications should be informed of the potential of quick rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb.

Such speed of recovery suggests a return to pre-treatment weight within about 18 months.

Comparing Treatments

The research, which examined dozens of studies involving thousands of patients, compared the effects of the injectable medications with older methods.

Scientists note that individuals who shed pounds through dieting typically experience a slower weight regain—perhaps 0.1 kg a month—post-intervention.

Explaining the Quick Regain

Experts believe the mechanism of the drugs explains the heightened weight return.

GLP-1 drugs copy a natural hormone called GLP-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 levels far above than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' means hunger is uncontrolled, making excessive eating far more likely."

An Ongoing Condition?

The NHS suggest the jabs for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

Professionals argue that, given the significant potential of weight regain, the treatment might need to be ongoing.

This opinion is echoed by drug manufacturers, who state that the results "underscore the long-term character of excess weight," akin to managing diseases like high blood pressure.

User Testimonies

People who have come off the jabs describe a sudden resurgence of appetite.

"I experienced something activating and you're instantly extremely hungry," described a patient.

The struggle is worsened if users have not developed permanent dietary or behavioural modifications during treatment.

Growing Adoption

Survey data indicate that millions of people in the UK have used these injections in the last 12 months, with desire remaining high.

  • Adoption is higher among females compared to men.
  • The middle-aged age group shows the greatest usage rates.
  • Many access the drugs through private prescriptions rather than public health services.

In conclusion, experts caution that while these medications are potent tools for shedding pounds, they are not a magic cure and lasting health benefits hinges on ongoing lifestyle changes.

Written by

Jonathan Curry

A digital content curator with a passion for global media trends and viral storytelling.

Global Reels Hub

Type to search articles.